Current Medicinal Chemistry
Title:Editorial: Different Classes of Natural Products as Promising Scaffolds for the Development of Therapeutic Agents: New Drugs from “Old” Natural Products
Volume: 25 Issue: 10
Author(s): Dall'Acqua Stefano*
Affiliation:
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35121, Padova,Italy
Export Options
About this article
Cite this article as:
Stefano Dall'Acqua *, Editorial: Different Classes of Natural Products as Promising Scaffolds for the Development of Therapeutic Agents: New Drugs from “Old” Natural Products, Current Medicinal Chemistry 2018; 25 (10) . https://dx.doi.org/10.2174/092986732510180409145323
DOI https://dx.doi.org/10.2174/092986732510180409145323 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Seasonal Allergic Rhinitis
Recent Patents on Inflammation & Allergy Drug Discovery Phytochemicals for Breast Cancer Therapy: Current Status and Future Implications
Current Cancer Drug Targets The Impact of Antiviral Treatments on the Course of Chronic Hepatitis C: An Evidence-Based Approach
Current Pharmaceutical Design Immunoglobulin VH Domains and Beyond Design and Selection of Single-Domain Binding and Targeting Reagents
Current Pharmaceutical Biotechnology Anti-Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor
Current Cancer Drug Targets Experimental Onco-Immunology Revisited
Current Cancer Therapy Reviews Pneumonia Due to Methicilin-Resistant Staphylococcus aureus (MRSA): A Review
Current Respiratory Medicine Reviews Editorial [Hot topic: Developing New Anti-Cancer Drugs (Guest Editor: Ricardo De Souza Pereira)]
Recent Patents on Anti-Cancer Drug Discovery Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets The Mechanisms of Gastric Mucosal Injury: Focus on Microvascular Endothelium as a Key Target
Current Medicinal Chemistry Targeting the Mevalonate Pathway for Improved Anticancer Therapy
Current Cancer Drug Targets Management of Peyronie's Disease after Collagenase (Xiaflex:<sup>®</sup>)
Current Drug Targets Psoriatic Arthritis and its Novel Therapeutics
Current Rheumatology Reviews Aminoglycoside-Induced Ototoxicity
Current Pharmaceutical Design Epigenetic Modification in Neuropathic Pain
Current Pharmaceutical Design Treatment of Central Nervous System Involvement Associated with Primary Sjogrens Syndrome
Current Pharmaceutical Design Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Combat Pneumococcal Infections: Adhesins as Candidates for Protein- Based Vaccine Development
Current Drug Targets Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives
Current Diabetes Reviews Anticoagulant Therapy in Pregnant Patients with Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology